Price to pay

The misuse of embryos

A 43-year-old woman rolls slowly out of bed, having dreamt the night before of her fifth-grade classroom—a room she knew well before taking disability leave. She makes her daily plea for a treatment that will allow her to get to the grocery store without tripping over her own feet. Meanwhile, a seven-year-old girl wakes up to check her insulin level. She adjusts the pump attached to her abdomen and wonders whether she will be able to eat the school lunch today, and whether she will eventually lose her sight.

These stories of people suffering from Parkinson’s disease and juvenile diabetes represent the plight of real people. Stem cell research using human embryos might mean new mornings for people like these—people you and I know by name. If embryonic stem cell research (ECSR) can alleviate such suffering, then is it not consonant with the Good News?


This article is available to subscribers only. Please subscribe for full access—subscriptions begin at $2.95. Already have an online account? Log in now. Already a print subscriber? Create an online account for no additional cost.

This article is available to subscribers only.

To post a comment, log inregister, or use the Facebook comment box.